IBD Research Resource Center

Clinical ID	c2476
Identifier	EUCTR2019-002942-19-DK
Trial Title	NORDTREAT_The Nordic IBD treatment strategy trial a randomized controlled trial of access to a protein profile_
Trial URL	Visit Original Page

Study Results	No results available
Conditions	Crohn's disease and Ulcerative colitis MedDRA version: 20.1_Level: LLT_Classification code 10045365_Term: Ulcerative colitis_System Organ Class: 10017947 - Gastrointestinal disorders_ MedDRA version: 20.0_Level: LLT_Classification code 10013099_Term: Disease Crohns_System Organ Class: 10017947 - Gastrointestinal disorders_;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Interventions	Trade Name: Remicade Infliximab Pharmaceutical Form: Powder for concentrate for solution for infusion INN or Proposed INN: INFLIXIMAB CAS Number: 170277-31-3 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 100- Trade Name: Humira Adalimumab Pharmaceutical Form: Solution for injection in pre-filled pen INN or Proposed INN: ADALIMUMAB CAS Number: 331731-18-1 Concentration unit: mg milligram(s) Concentration type: range Concentration number: 20-80 Trade Name: Imurel Azatioprin Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Azathioprine CAS Number: 446-86-6 Concentration unit: mg milligram(s) Concentration type: range Concentration number: 25-100 Trade Name: Puri-nethol Merkaptopurin Pharmaceutical Form: Tablet INN or Proposed INN: MERCAPTOPURINE CAS Number: 50-44-2 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 50-

Sex Requirement	NOT SPECIFIED
Age Requirement	-

Study Type	Interventional clinical trial of medicinal product
Phase	PHASE4